Related references
Note: Only part of the references are listed.Regulation of CD4(+)NKG2D(+) Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15R alpha and NKG2D Triggering
Ana I. Romero et al.
CANCER RESEARCH (2014)
Phase 2 Southwest Oncology Group-directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas
Margaret von Mehren et al.
CANCER (2012)
Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma
Robert J. Canter et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma
David Roberge et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Radio sensitivity Translates Into Excellent Local Control in Extremity Myxoid Liposarcoma A Comparison With Other Soft Tissue Sarcomas
Peter W. M. Chung et al.
CANCER (2009)
Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
Nabeel Pervaiz et al.
CANCER (2008)
Cell cycle-dependent and schedule-dependent antitumor effects of sorafenib combined with radiation
John P. Plastaras et al.
CANCER RESEARCH (2007)
Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results
Brian G. Czito et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Opportunities for improving the therapeutic ratio for patients with sarcoma
Jay S. Wunder et al.
LANCET ONCOLOGY (2007)
Design of clinical trials of radiation combined with antiangiogenic therapy
Suresh Senan et al.
ONCOLOGIST (2007)
Angiogenic profile of soft tissue sarcomas based on analysis of circulating factors and microarray gene expression
Sam S. Yoon et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Phase II placebo-controlled randomized discontinuation trial of sorafnib in patients with metastatic renal cell carcinoma
Mark J. Ratain et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade
J Li et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
A Awada et al.
BRITISH JOURNAL OF CANCER (2005)
Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
D Strumberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma
SS Yoon et al.
ANNALS OF ONCOLOGY (2004)
Ras-dependent induction of HIF-1a785 via the Raf/MEK/ERK pathway:: a novel mechanism of Ras-mediated tumor promotion
JH Lim et al.
ONCOGENE (2004)
Phase I trial design for solid tumor studies of targeted, non-cytotoxic agents: Theory and practice
WR Parulekar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Radiation response: An additional unique signature of myxoid liposarcoma
G Pitson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Ifosfamide in the adjuvant therapy of soft tissue sarcomas
S Frustaci et al.
ONCOLOGY (2003)
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
RK Jain
SEMINARS IN ONCOLOGY (2002)
Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma
R Petrioli et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
B O'Sullivan et al.
LANCET (2002)
Angiogenesis and lymphangiogenesis in tumors: Insights from intravital microscopy
RK Jain
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2002)
Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas
K Yudoh et al.
BRITISH JOURNAL OF CANCER (2001)
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma
E Gortzak et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
